4YX-25085-26215

3 vaccinations 17 coded responses 38 check-ins 17 free-text entries 7 call cases

Sex: Female
Age at first dose: 26-30
ZIP prefix: 009 / PR
Registered: 2020-12-28

Relationship: Self
Race: Other
Ethnicity: Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-28
Registered in v-safe
2020-12-28
Dose 1 — Pfizer-BioNTech
2020-12-28
Survey response — day 0, dose 1
MedDRA: Chest pain, Dyspnoea, Immediate post-injection reaction, Injection site pain — Feeling: Fair · Site: Pain

Free text: Shortness of breath 5 minutes after vaccine. It lasted for about 10 minutes. Three hours later, I experienced pain at the injection site, as well as chest pain, but the chest pain subsided after approximately 40 minutes.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-29
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-30
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-31
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Joint pains

Adult check-in
2021-01-01
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-02
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-03
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-04
Survey response — day 7, dose 1
MedDRA: Oropharyngeal pain — Feeling: Fair · Headache

Free text: Sore throat that comes and goes

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-12
Survey response — day 14, dose 1
MedDRA: Chills, Oropharyngeal pain — Feeling: Good

Free text: Sore throat (comes and goes), I experienced chills two nights ago (no fever)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-15
Dose 2 — Pfizer-BioNTech
2021-01-15
Health check-in — day 0, dose 2
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2021-01-16
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2021-01-18
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-19
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache

Adult check-in
2021-01-21
Survey response — days 1–6 daily, dose 2
MedDRA: Oropharyngeal pain — Feeling: Good

Free text: Sore throat (comes and goes)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-22
Survey response — day 7, dose 2
MedDRA: Oropharyngeal pain — Feeling: Good

Free text: Intermittent sore throat (stabbing pain)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-29
Survey response — day 14, dose 2
MedDRA: Headache, Lymphadenopathy, Malaise, Nausea — Feeling: Fair

Free text: Unilateral Axillary lymphadenopathy, nausea, general malaise, headache

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-05
Survey response — day 21, dose 2
MedDRA: Asthenia, Dizziness, Lymphadenopathy, Malaise, Nausea — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: After day 9 of the 2nd dose: general lymphadenopathy, general malaise, nausea, weakness, lightheaded. Lab work showed high monocytes and positive igG. These symptoms lasted for two weeks after day 9. Doctor ruled out infectious process.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-05
Report sent to call center — day 21, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-02-12
Survey response — day 28, dose 2
MedDRA: Lymphadenopathy — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: General lymphadenopathy

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-12
Report sent to call center — day 28, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-02-19
Survey response — day 35, dose 2
MedDRA: Lymph node pain — Feeling: Good

Free text: Pain in other lymph nodes.. but other symptoms have disappeared. IgG positive. PCR negative. High monocytes and WBC. No source of infection found..

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-26
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-16
Survey response — 3 months, dose 2
MedDRA: Lung disorder, Lymphadenopathy — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Lymphadenopathy; mild restrictive lung defect; moderate decrease in diffusing capacity

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-16
Report sent to call center — 3 months, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-06-15
Call 1 — Left Voicemail
2021-07-16
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-10-01
Dose 3 — Pfizer-BioNTech
2021-10-01
Health check-in — day 0, dose 3
Feeling: Good · Site: Pain · None

Adult check-in
2021-10-02
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain · None

Adult check-in
2021-10-03
Survey response — days 1–6 daily, dose 3
MedDRA: Dyspnoea — Feeling: Fair · Site: Pain

Free text: Shortness of breath

MedDRA releases: 2024-11 · check-in free text available
2021-10-04
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-10-05
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-10-06
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-10-07
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-10-08
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2021-10-15
Health check-in — day 14, dose 3
Feeling: Fair

Adult check-in
2021-10-22
Survey response — day 21, dose 3
MedDRA: Migraine — Feeling: Good · Be unable to do your normal daily activities

Free text: Migraines

MedDRA releases: 2024-11 · check-in free text available
2021-10-29
Survey response — day 28, dose 3
MedDRA: Fatigue — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Tiredness, fatigue

MedDRA releases: 2024-11 · check-in free text available
2021-11-05
Health check-in — day 35, dose 3
Feeling: Fair

Adult check-in
2021-11-12
Survey response — day 42, dose 3
MedDRA: Fatigue, Malaise, Nausea, Pain — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: General malaise, fatigue, nausea, body aches

MedDRA releases: 2024-11 · check-in free text available
2021-11-12
Report sent to call center — day 42, dose 3
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2021-11-14
Call successful
Participant prefers to complete VAERS report online
2021-11-15
Call successful
Participant prefers to complete VAERS report online
2021-11-15
Call successful
Participant prefers to complete VAERS report online
2021-11-15
Call successful
Participant prefers to complete VAERS report online
2021-12-31
Survey response — 3 months, dose 3
MedDRA: Hypertension — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit

Free text: Diagnosed with hypertension

MedDRA releases: 2024-11 · check-in free text available
2021-12-31
Report sent to call center — 3 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
2022-01-05
Call 1 — Left Voicemail
2022-04-01
Survey response — 6 months, dose 3
MedDRA: Anti-thyroid antibody positive, Hypertension — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit

Free text: Hypertension, positive TPO

MedDRA releases: 2024-11 · check-in free text available
2022-04-01
Report sent to call center — 6 months, dose 3
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
2022-04-06
Call 1 — Could Not Reach Participant
2022-04-11
Call 2 — Left Voicemail
2022-10-03
Survey response — 12 months, dose 3
MedDRA: Fatigue, Hypertension, Migraine — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: Fatigue, tiredness, migraines, hypertension

MedDRA releases: 2024-11 · check-in free text available
2022-10-03
Report sent to call center — 12 months, dose 3
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
2022-10-05
Call 2 — Could Not Reach Participant
2022-10-05
Call 1 — Could Not Reach Participant
2022-10-05
Call 1 — Could Not Reach Participant
2022-10-05
Call 1 — Could Not Reach Participant
2022-10-05
Call 2 — Could Not Reach Participant
2022-10-05
Call 3 — Could Not Reach Participant
2022-10-05
Call 1 — Could Not Reach Participant
2022-10-07
Call 3 — Left Voicemail
2022-10-07
Call X — Left Voicemail
2022-10-07
Call 2 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-28	Pfizer-BioNTech
2	2021-01-15	Pfizer-BioNTech
3	2021-10-01	Pfizer-BioNTech	No

Call center

7 call center cases

4 successful · 3 unsuccessful

4 waits over 3 months for a first call

See the call center timeline

Free text

Release 1 — day 0, dose 1

2020-12-28

Systemic reaction (other): Shortness of breath 5 minutes after vaccine. It lasted for about 10 minutes. Three hours later, I experienced pain at the injection site, as well as chest pain, but the chest pain subsided after approximately 40 minutes.

Release 1 — day 7, dose 1

2021-01-04

Systemic reaction (other): Sore throat that comes and goes

Release 1 — day 14, dose 1

2021-01-12

Symptoms: Sore throat (comes and goes), I experienced chills two nights ago (no fever)

Release 2 — days 1–6 daily, dose 2

2021-01-21

Systemic reaction (other): Sore throat (comes and goes)

Release 2 — day 7, dose 2

2021-01-22

Systemic reaction (other): Intermittent sore throat (stabbing pain)

Release 3 — day 14, dose 2

2021-01-29

Symptoms: Unilateral Axillary lymphadenopathy, nausea, general malaise, headache

Release 3 — day 21, dose 2

2021-02-05

Symptoms: After day 9 of the 2nd dose: general lymphadenopathy, general malaise, nausea, weakness, lightheaded. Lab work showed high monocytes and positive igG. These symptoms lasted for two weeks after day 9. Doctor ruled out infectious process.

Release 4 — day 28, dose 2

2021-02-12

Symptoms: General lymphadenopathy

Release 4 — day 35, dose 2

2021-02-19

Symptoms: Pain in other lymph nodes.. but other symptoms have disappeared. IgG positive. PCR negative. High monocytes and WBC. No source of infection found..

Release 7 — 3 months, dose 2

2021-04-16

Symptoms: Lymphadenopathy; mild restrictive lung defect; moderate decrease in diffusing capacity

Release 9 — days 1–6 daily, dose 3

2021-10-03

Systemic reaction (other): Shortness of breath

Release 10 — day 21, dose 3

2021-10-22

Symptoms: Migraines

Release 10 — day 28, dose 3

2021-10-29

Symptoms: Tiredness, fatigue

Release 10 — day 42, dose 3

2021-11-12

Symptoms: General malaise, fatigue, nausea, body aches

Release 10 — 3 months, dose 3

2021-12-31

Symptoms: Diagnosed with hypertension

Release 11 — 6 months, dose 3

2022-04-01

Symptoms: Hypertension, positive TPO

Release 12 — 12 months, dose 3

2022-10-03

Symptoms: Fatigue, tiredness, migraines, hypertension

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Anti-thyroid antibody positive	·	·	✓
SD	Asthenia	✓	✓	✓
SD	Chills	✓	✓	✓
SD	Dizziness	✓	✓	✓
SD	Fatigue	·	·	✓
SD	Headache	✓	✓	✓
SD	Hypertension	·	·	✓
SD	Lung disorder	✓	✓	✓
SD	Lymph node pain	✓	✓	✓
SD	Lymphadenopathy	✓	✓	✓
SD	Malaise	✓	✓	✓
SD	Migraine	·	·	✓
SD	Nausea	✓	✓	✓
SD	Oropharyngeal pain	✓	✓	✓
SD	Pain	·	·	✓
SRO	Chest pain	✓	✓	✓
SRO	Dyspnoea	✓	✓	✓
SRO	Immediate post-injection reaction	✓	✓	✓
SRO	Injection site pain	✓	✓	✓
SRO	Oropharyngeal pain	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release